{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:07Z","timestamp":1793724247722,"version":"4.6.1"},"reference-count":138,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:p>Glycyrrhetinic Acid and its salts and esters and Glycyrrhizic Acid and its salts and esters are cosmetic ingredients that function as flavoring agents or skin-conditioning agents\u2014miscellaneous or both. These chemicals may be isolated from licorice plants. Glycyrrhetinc Acid is described as at least 98% pure, with 0.6% 24-OH-Glycyrrhetinic Acid, not more than 20 \ue715g\/g of heavy metals and not more than 2 \ue715g\/g of arsenic. Ammonium Glycyrrhizate has been found to be at least 98% pure and Dipotassium Glycyrrhizate has been found to be at least 95% pure. Glycyrrhetinic Acid is used in cosmetics at concentrations of up to 2%; Stearyl Glycyrrhetinate, up to 1%; Glycyrrhizic Acid, up to 0.1%; Ammonium Glycyrrhizate, up to 5%; Dipotassium Glycyrrhizate, up to 1%; and Potassium Glycyrretinate, up to 1%. Although Gly-cyrrhizic Acid is poorly absorbed by the intestinal tract, it may be hydrolyzed to Glycyrrhetinic Acid by a \u03b2-glucuronidase produced by intestinal bacteria. Glycyrrhetinic Acid and Glycyrrhizic Acid bind to rat and human albumin, but do not absorb well into tissues. Glycyrrhetinic Acid and Glycyrrhizic Acid and metabolites are mostly excreted in the bile, with very little excreted in urine. Dipotassium Glycyrrhizate was undetectable in the receptor chamber when tested for transepidermal permeation through pig skin. Glycyrrhizic Acid increased the dermal penetration of diclofenac sodium in rat skin. Dipotassium Glycyrrhizate increased the intestinal absorption of calcitonin in rats. In humans, Glycyrrhetinic Acid potentiated the effects of hydrocortisone in the skin. Moderate chronic or high acute exposure to Glycyrrhizic Acid, Ammonium Glycyrrhizate, and their metabolites have been demonstrated to cause transient systemic alterations, including increased potassium excretion, sodium and water retention, body weight gain, alkalosis, suppression of the renin-angiotensis-aldosterone system, hypertension, and muscular paralysis; possibly through inhibition of 11 \u03b2-hydroxysteroid dehydrogenase-2 (11\u03b2-OHSD2) in the kidney. Glycyrrhetinic Acid and its derivatives block gap junction intracellular communication in a dose-dependent manner in animal and human cells, including epithelial cells, fibroblasts, osteoblasts, hepatocytes, and astrocytes; at high concentrations, it is cytotoxic. Glycyrrhetinic Acid and Glycyrrhizic Acid protect liver tissue from carbon tetrachloride. Glycyrrhizic Acid has been used to treat chronic hepatitis, inhibiting the penetration of the hepatitis A virus into hepatocytes. Glycyrrhetinic Acid and Glycyrrhizic Acid have anti-inflammatory effects in rats and mice. The acute in-traperitoneal LD50 for Glycyrrhetinic Acid in mice was 308 mg\/kg and the oral LD50 was &gt; 610 mg\/kg. The oral LD50 in rats was reported to be 610 mg\/kg. Higher LD50 values were generally reported for salts. Little short-term, subchronic, or chronic toxicity was seen in rats given ammonium, dipotassium, or disodium salts of Glycyrrhizic Acid. Glycyrrhetinic Acid was not irritating to shaved rabbit skin, but was considered slightly irritating in an in vitro test. Glycyrrhetinic Acid inhibited the mutagenic activity of benzo[a]pyrene and inhibited tumor initiation and promotion by other agents in mice. Glycyrrhizic Acid inhibited tumor initiation by another agent, but did not prevent tumor promotion in mice. Glycyrrhizic Acid delayed mortality in mice injected with Erlich ascites tumor cells, but did not reduce the mortality rate. Ammonium Glycyrrhizate was not genotoxic in in vivo and in vitro cytogenetics assays, the dominant lethal assay, an Ames assay, and heritable translocation tests, except for possible increase in dominant lethal mutations in rats given 2000 mg\/kg day-1 in their diet. Disodium Glycyrrhizate was not carcinogenic in mice in a drinking water study at exposure levels up to 12.2 mg\/kg day -1 for 96 weeks. Glycyrrhizate salts produced no reproductive or developmental toxicityin rats, mice, golden hamsters, or Dutch-belted rabbits, except for a dose-dependent increase (at 238.8 and 679.9 mg\/kg day -1) in sternebral variants in a study using rats. Sedation, hypnosis, hypothermia, and respiratory depression were seen in mice given 1250 mg\/kg Glycyrrhetinic Acid intraperitoneally. Rats fed a powdered diet containing up to 4% Ammonium Glycyrrhizate had no treatment related effects in motor function tests, but active avoidance was facilitated at 4%, unaffected at 3%, and depressed at 2%. In a study of 39 healthy volunteers, a no effect level of 2 mg\/kg\/day was determined for Glycyrrhizic Acid given orally for 8 weeks. Clinical tests in seven normal individuals given oral Ammonium Glycyrrhizate at 6 g\/day for 3 days revealed reduced renal and thermal sweat excretion of Na+ and K+, but carbohydrate and protein metabolism were not affected. Glycyrrhetinic Acid at concentrations up to 6% was not a skin irritant or a sensitizer in clinical tests. Neither Glycyrrhizic Acid, Ammonium Glycyrrhizate, nor Dipotassium Glycyrrhizate at 5% were phototoxic agents or photosensitizers. Birth weight and maternal blood pressure were unrelated to the level of consumption of Glycyrrhizic Acid in 1049 Finnish women with infants, but babies whose mother consumed &gt;500 mg\/wk were more likely to be born before 38 weeks. The Cosmetic Ingredient Review (CIR) Expert Panel noted that the ingredients in this safety assessment are not plant extracts, powders, or juices, but rather are speci.c chemical species that may be isolated from the licorice plant. Because these chemicals may be isolated from plant sources, however, steps should be taken to assure that pesticide and toxic metal residues are below acceptable levels. The Panel advised the industry that total polychlorobiphenyl (PCB)\/pesticide contamination should be limited to not more than 40 ppm, with notmore than 10ppmfor any speci.c residue, and that toxic metal levels must not contain more than 3 mg\/kg of arsenic (as As), not more than 0.002% heavy metals, and not more than 1 mg\/kg of lead (as Pb). Although the Panel noted that Glycyrrhizic Acid is cytotoxic at high doses and ingestion can have physiological effects, there is little acute, short-term, subchronic, or chronic toxicity and it is expected that these ingredientswould be poorly absorbed through the skin. These ingredients are not considered to be irritants, sensitizers, phototoxic agents, or photosensitizers at the current maximum concentration of use. Accordingly, the CIR Expert Panel concluded that these ingredients are safe in the current practices of use and concentration. The Panel recognizes that certain ingredients in this group are reportedly used in a given product category, but the concentration of use is not available. For other ingredients in this group, information regarding use concentration for speci.c product categories is provided, but the number of such products is not known. In still other cases, an ingredient is not in current use, but may be used in the future. Although there are gaps in knowledge about product use, the overall information available on the types of products in which these ingredients are used and at what concentration indicate a pattern of use. Within this overall pattern of use, the Expert Panel considers all ingredients in this group to be safe.<\/jats:p>","DOI":"10.1080\/10915810701351228","type":"journal-article","created":{"date-parts":[[2007,7,6]],"date-time":"2007-07-06T09:53:20Z","timestamp":1183715600000},"page":"79-112","source":"Crossref","is-referenced-by-count":51,"title":["Final Report on the Safety Assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate1"],"prefix":"10.1177","volume":"26","member":"179","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"atypb1","first-page":"535","volume":"56","year":"1982","journal-title":"Microbiol. Immunol."},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1080\/01635589109514126"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1994.tb03756.x"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.20.1245"},{"key":"atypb5","unstructured":"Allergisa Pesquisa Dermato-Cosm\u00e9tica Ltd. 2004a. Clinical Single-Blind Randomized Controlled Study on the Potential for Cutaneous Sensitization of the Product 0.6% 18\n                      \u03b2\n                      -Glycyrrhetic Acid Sol. (LAB. NO. 040729; Lot No. 20404E009). Unpublished data submitted by CTFA. 14 pages."},{"key":"atypb6","unstructured":"Allergisa Pesquisa Dermato-Cosm\u00e9tica Ltd. 2004b. Clinical Single-Blind Randomized, Controlled Study on the Potential of Primary Cutaneous Irritation of the Product 0.6% 18\n                      \u03b2\n                      -Glychrrhetic Acid Sol. (Lab. No. 040729; Lot No. 20404E009). Unpublished data submitted by CTFA. 13 pages."},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.7.923"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(93)90254-7"},{"key":"atypb9","first-page":"91","volume":"29","year":"1997","journal-title":"J. Commun. Dis."},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1007\/s004240100588"},{"key":"atypb11","first-page":"431","volume":"130","year":"1991","journal-title":"Boll. Chim. Farmaceutico."},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.85.4.1543"},{"key":"atypb13","unstructured":"Budivari, S., M. J. O'Neil, A. Smith, P. E. Heckelman, eds. 1989.The Merck Index. An encyclopedia of chemicals, drugs, and biologicals, 7th ed.Rahway, NJ: Merck & Co., 244 and 4400."},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102s965"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1997.0169"},{"key":"atypb16","first-page":"113","volume":"12","year":"2001","journal-title":"Semin. Gastroin-test. Dis."},{"key":"atypb17","unstructured":"Clinical Science Research International, Ltd. (CSRI). 1992a. Photosensitization study. Unpublished data submitted by CTFA on September 16, 2004. 13 pages."},{"key":"atypb18","unstructured":"CSRI. 1992b. Dermal phototoxicity data. Unpublished data submitted by CTFA on September 16, 2004. 15 pages."},{"key":"atypb19","unstructured":"Cognis. 2002. Information regarding glycyrrhetinic acid, dipotassium gly-cyrrhizate, ammonium glycyrrhizate. Unpublished data submitted by CTFA on July 19, 2004. 46 pages."},{"key":"atypb20","first-page":"600","volume":"178","year":"1957","journal-title":"Practitioner."},{"key":"atypb21","first-page":"80","volume":"205","year":"1968","journal-title":"JAMA."},{"key":"atypb22","unstructured":"Consumer Product Testing Company. 2002. Repeated Insult Patch Test Protocol No.: 1.01. Unpublished data submitted to CTFA on July 19, 2004. 13 pages."},{"key":"atypb23","unstructured":"Cosmetic, Toiletry and Fragrance Association (CTFA). 2003. Concentration of use-Allantoin Glycyrrhetinic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinic Acid, Glycyrrhetinyl Stearate, Glycyrrhiza Glabra (Licorice), Glycyrrhiza Glabra (Licorice) Root Extract, Glycyrrhizic Acid, Methyl Glycyrrhizate, Stearyl Glycyrrhetinate. Unpublished data submitted by CTFA on September 16, 2003."},{"key":"atypb24","unstructured":"CTFA. 2004. UVabsorbance of licorice ingredients. Unpublished data submitted by CTFA on April 26, 2004. 4 pages."},{"key":"atypb25","unstructured":"CTFA. 2004. Allergen data for licorice ingredients. Unpublished data submitted by CTFA on November 23, 2004. 14 pages."},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(94)90033-7"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01224.x"},{"key":"atypb28","first-page":"1104","volume":"264","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(91)90179-V"},{"key":"atypb30","first-page":"1161","volume":"12","year":"1956","journal-title":"BMJ."},{"key":"atypb31","unstructured":"European Commission's Scientific Committee on Food (SCF). 2003. Opinion of the scientific committee on food on glycyrrhizinic acid and its ammonium salt. Available at http: \/\/europa.eu.int\/comm\/food\/fs\/sc\/scf\/out186 en.pdf."},{"key":"atypb32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1742-1241.1958.tb06108.x","volume":"12","year":"1958","journal-title":"Br. J. Clin. Pract."},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1958.tb10361.x"},{"key":"atypb34","unstructured":"Food and Drug Administration (FDA). 2002. Frequency of use of cosmetic ingredients.\n                      FDA database.\n                      Washington, DC: FDA."},{"key":"atypb35","unstructured":"Food and Drug Research Laboratories (FDRL). 1971a. Acute oral toxicity of ammonium glycyrrhizinate in rabbits. Submitted by FDA in response to an FOI request-2001. 8 pages."},{"key":"atypb36","unstructured":"FDRL. 1971b. Teratologic evaluation of FDA 71-1 (ammonium glycyrrhizinate). NTIS Report No. PB221793."},{"key":"atypb37","unstructured":"Fujimura, H. No date. Test onacute toxicity of crude ammonium glycyrrhizinate, crude potassium glycyrrhizinate, and mono-ammonium glycyrrhizinate. Submitted by FDA in response to an FOI request-2001. 18 pages."},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-68255-4_173"},{"key":"atypb39","unstructured":"Generoso, W. M., K. T. Cain, C. Cornett, and N. L. A. Cacheiro. 1983. Heritable translocation test of three GRAS compounds, ammoniated glycyrrhizin, buty-lated hydroxytoluene, and gum arabic in mice. Submitted by FDA in response to an FOI request. 30 pages."},{"key":"atypb40","volume-title":"International cosmetic ingredient dictionary and handbook","year":"2004"},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92380-Z"},{"key":"atypb42","first-page":"49","volume":"1","year":"1977","journal-title":"J. Environ. Pathol. Toxicol."},{"key":"atypb43","first-page":"625","volume":"15","year":"1961","journal-title":"Ind. J. Med. Sci."},{"key":"atypb44","first-page":"L1018","volume":"276","year":"1999","journal-title":"Am. J. Physiol."},{"key":"atypb45","unstructured":"Hill Laboratories Limited. 2004. Results of Residue Testing of Glycyrrhetic Acid. Unpublished data submitted by CTFA on October 14, 2004. 1 page."},{"key":"atypb46","unstructured":"Hilltop Research, Inc. 1994. Human repeated insult patch test. Report No. 93-2367-72C. Unpublished data submitted by CTFA on September 16, 2004. 10 pages."},{"key":"atypb47","unstructured":"Hilltop Research, Inc. 1995. Human repeated insult patch test. Revised report No. 94-6400-76A. Unpublished data submitted by CTFA on September 16, 2004. 27 pages."},{"key":"atypb48","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.54"},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5718(01)00214-5"},{"key":"atypb50","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600750711"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(00)00079-6"},{"key":"atypb52","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018822829302"},{"key":"atypb53","unstructured":"Informatics, Inc. 1972. Monograph on Glycyrrhiza. Submitted by FDA in response to an FOI request. 35 pages."},{"key":"atypb54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11801.x"},{"key":"atypb55","unstructured":"Inverni della Beffa. 1970. Glycamil: tolerance and toxicity. Submitted by FDA in response to an FOI request. 31 pages."},{"key":"atypb56","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.37.2509"},{"key":"atypb57","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.40.1917"},{"key":"atypb58","doi-asserted-by":"publisher","DOI":"10.3358\/shokueishi.26.460"},{"key":"atypb59","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2001.23"},{"key":"atypb60","first-page":"85","volume":"3","year":"1994","journal-title":"Cancer Epidemiol. Biomarkers Prevent."},{"key":"atypb61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3565(24)37203-9","volume":"284","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"atypb62","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-969714"},{"key":"atypb63","doi-asserted-by":"publisher","DOI":"10.1159\/000226348"},{"key":"atypb64","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(85)90247-9"},{"key":"atypb65","unstructured":"Lachartre Laboratories. 1992a. Clinical assessment of the cutaneous tolerance to a daily repeated application of the product RE-0323.01 under the normal conditions of use. Unpublished data submitted by CTFA on September 16, 2004. 12 pages."},{"key":"atypb66","unstructured":"Lachartre Laboratories. 1992b. Clinical assessment of the cutaneous tolerance to a repeated application of the product under occlusive dressing RE-0323.01 according to the procedure of Marzulli and Maibach. Unpublished data submitted by CTFA on September 16, 2004. 14 pages."},{"key":"atypb67","volume-title":"CRC handbook of chemistry and physics","year":"1993"},{"key":"atypb68","unstructured":"Life Science Research Organization. 1974. Evaluation of the health aspects of licorice, glycyrrhiza, and ammoniated glycyrrhizin as food ingredients. NTIS Report No. PB254529."},{"key":"atypb69","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(98)00263-3"},{"key":"atypb70","unstructured":"Litton Bionetics. 1972. Summary of mutagenicity screening studies: ammo-niated glycyrrhizin. Submitted by FDA in response to an FOI request. 118 pages."},{"key":"atypb71","doi-asserted-by":"publisher","DOI":"10.1080\/02652030116955"},{"key":"atypb72","first-page":"20","volume":"47","year":"1956","journal-title":"J. Lab. Clin. Med."},{"key":"atypb73","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(88)90054-3"},{"key":"atypb74","unstructured":"Maruzen Pharmaceuticals Company, Ltd. 2004. Analysis of Glycyrrhetinic Acid. Unpublished data submitted by CTFA on October 14, 2004. 3 pages."},{"key":"atypb75","first-page":"381","volume":"2","year":"1950","journal-title":"Lancet."},{"key":"atypb76","unstructured":"Monlux, W. S. 1974. Report of lesions in rats fed ammonium glycyrrhizin. Submitted by FDA in response to an FOI request-2001. 5 pages."},{"key":"atypb77","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.158.25"},{"key":"atypb78","doi-asserted-by":"publisher","DOI":"10.1007\/BF00118193"},{"key":"atypb79","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/5.11.1529"},{"key":"atypb80","first-page":"33","volume":"77","year":"1986","journal-title":"Jpn. J. Cancer Res."},{"key":"atypb81","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(64)90127-8"},{"key":"atypb82","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-827X(02)01298-3"},{"key":"atypb83","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-959435"},{"key":"atypb84","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(90)90132-H"},{"key":"atypb85","doi-asserted-by":"publisher","DOI":"10.1016\/0161-4630(81)90033-1"},{"key":"atypb86","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.1161"},{"key":"atypb87","doi-asserted-by":"publisher","DOI":"10.1177\/146642400012000203"},{"key":"atypb88","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(97)01154-5"},{"key":"atypb89","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1963.tb12825.x"},{"key":"atypb90","first-page":"220","volume":"4","year":"1999","journal-title":"Altern. Med. Rev."},{"key":"atypb91","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2000.9078"},{"key":"atypb92","doi-asserted-by":"publisher","DOI":"10.1081\/DMR-100104400"},{"key":"atypb93","doi-asserted-by":"publisher","DOI":"10.1038\/281689a0"},{"key":"atypb94","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.2.801"},{"key":"atypb95","unstructured":"Quintiles. 1999. Human repeated insult patch test. Unpublished data submitted by CTFA on September 16, 2004. 15 pages."},{"key":"atypb96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1999.tb02012.x"},{"key":"atypb97","first-page":"183","volume":"9","year":"1995","journal-title":"In Vivo."},{"key":"atypb98","first-page":"317","volume":"8","year":"1994","journal-title":"In Vivo."},{"key":"atypb99","first-page":"447","volume":"154","year":"2001","journal-title":"Methods Mol. Biol."},{"issue":"27","key":"atypb100","first-page":"7","year":"1997","journal-title":"J. Cell. Biochem."},{"key":"atypb101","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.906"},{"key":"atypb102","first-page":"574","volume":"20","year":"1980","journal-title":"La Kromosomo II."},{"key":"atypb103","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00458-0"},{"key":"atypb104","first-page":"51","volume":"45","year":"2001","journal-title":"Acta Virol."},{"key":"atypb105","doi-asserted-by":"publisher","DOI":"10.1002\/em.2860080305"},{"key":"atypb106","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4800(89)90006-3"},{"key":"atypb107","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001215"},{"key":"atypb108","first-page":"37","volume":"3","year":"1981","journal-title":"Neurobe-hav. Toxicol. Teratol."},{"key":"atypb109","doi-asserted-by":"publisher","DOI":"10.1080\/02652039009373939"},{"key":"atypb110","unstructured":"Stanford Research Institute. 1977. Study of the mutagenic effects of ammoniated glycyrrhizin (17-1) by the dominant lethal test in rats. Submitted by FDA in response to an FOI request. 72 pages."},{"key":"atypb111","unstructured":"St. Marianna University. 1995. Human skin irritation and photo toxicity test on licorice ingredients.\n                      Nishinihon J. Dermatol.\n                      57: 601-806. English translation summary submitted by CTFA on April 26, 2004. 2 pages."},{"key":"atypb112","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.11.1085"},{"key":"atypb113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00476.x"},{"key":"atypb114","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.18.288"},{"key":"atypb115","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.484"},{"key":"atypb116","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510140707"},{"key":"atypb117","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(65)90305-9"},{"key":"atypb118","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92633-S"},{"key":"atypb119","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.9.95"},{"key":"atypb120","first-page":"267","volume":"3","year":"1988","journal-title":"Drug Design Deliv."},{"key":"atypb121","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00266-1"},{"key":"atypb122","unstructured":"Uemura, T. No date. Studies of stearyl glycyrrhetinate on its irritability to the skin. Unpublished data submitted by CTFA on April 26, 2004. 1 page."},{"key":"atypb123","unstructured":"Universita' Delgi Studi Di Urbino. 1990. Tolerability and cutaneous sensiti-zation study in healthy volunteers after topical application of the product (r) glycyrrhetinic acid-Phytosome ointment. Unpublished data submitted by CTFA on June 4, 2004. 36 pages."},{"key":"atypb124","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2001.0847"},{"key":"atypb125","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.551"},{"key":"atypb126","doi-asserted-by":"publisher","DOI":"10.1191\/096032700682694251"},{"key":"atypb127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04049.x"},{"key":"atypb128","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/12.2.187"},{"key":"atypb129","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.18.1238"},{"key":"atypb130","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.17.1399"},{"key":"atypb131","doi-asserted-by":"publisher","DOI":"10.1207\/S15327914nc391_1"},{"key":"atypb132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03912.x"},{"key":"atypb133","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1967.tb09583.x"},{"key":"atypb134","unstructured":"Yamamoto, K. 1976a. Human patch tests. Unpublished data submitted by CTFA on December 9, 2003. 3 pages."},{"key":"atypb135","unstructured":"Yamamoto, K. 1976b. Studies of glycyrrhizic acid and its salts on skin irritation and photosensitization. Unpublished data submitted by CTFA on April 26, 2004. 1 page."},{"key":"atypb136","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600811018"},{"key":"atypb137","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.18.337"},{"key":"atypb138","first-page":"528","volume":"79","year":"1993","journal-title":"Immunology."}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810701351228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810701351228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:22:36Z","timestamp":1777458156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/10915810701351228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":138,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1080\/10915810701351228"],"URL":"https:\/\/doi.org\/10.1080\/10915810701351228","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}